The challenges of the pandemic and the vaccination against covid-19 in pediatric patients with kidney disease

• Autor(a) principal: Soeiro,Emília Maria Dantas
• Data de Publicação: 2022
• Outros Autores: Penido,Maria Goretti Moreira Guimarães, Palma,Lilian Monteiro Pereira, Bresolin,Nilzete Liberato, Lima,Eduardo Jorge da Fonseca, Koch,Vera Hermina Kalika, Tavares,Marcelo de Sousa, Sylvestre,Lucimary, Bernardes,Rejane de Paula, Garcia,Clotilde Druck, Andrade,Maria Cristina de, Kaufman,Arnauld, Chow,Charles Yea Zen, Martins,Suelen Bianca Stopa, Camargo,Suzana Friedlander Del Nero
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Jornal Brasileiro de Nefrologia
• Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002022005054401
• topic: Vaccines; Covid-19; Hemolytic-Uremic Syndrome; Nephrotic Syndrome; Renal Insufficiency; Chronic; Kidney transplantation

ABSTRACT The covid-19 vaccine confers direct protection and reduces transmission rates of the virus and new variants. Vaccines from Pfizer/BioNTech and CoronaVac have been cleared for children in Brazil. They are safe, effective, and immunogenic. There are no known complications associated with the use of steroids or vaccines in pediatric patients with covid-19 and nephrotic syndrome. With or without immunosuppression, these patients are not at increased risk of severe covid-19, and steroids are safe for them. A milder form of covid-19 occurs in patients with chronic kidney disease without the need for hospitalization. The vaccine response may be reduced and/or the duration of antibodies after vaccination may be shorter than in the general population. However, considering risk of exposure, vaccination against covid-19 is recommended. It is believed that patients with hemolytic-uremic syndrome are at higher risk of severe covid-19. Vaccination is recommended, although specific data on the safety and efficacy of the covid-19 vaccine are limited. There is agreement that the benefits of induced immunity outweigh the risks of immunization. Vaccination against covid-19 is recommended for children and adolescents needing kidney transplantation or who have undergone transplantation. These patients present decreased immune response after vaccination, but immunization is recommended because the benefits outweigh the risks of vaccination. Current recommendations in Brazil stipulate the use of the messenger RNA vaccine. This paper aims to provide pediatric nephrologists with the latest knowledge about vaccination against covid-19 for children with kidney disease.